
News Feed
Gross Revenues of over 12 Million […]
(TSX VENTURE:BTI) (OTCQX:BIOAF) […]
(OTCQX: DMPI) […]
(TSX VENTURE:LMR)(OTCQX:LMRMF) […]
VANCOUVER and MENLO PARK,Calif., Dec. 2, 2014 /PRNewswire/ — DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) (“DelMar” and “DelMar Pharma”), a clinical stage drug development company focused on the development and commercialization of a new chemotherapy for the treatment of refractory glioblastoma […]
Elk Creek, Nebraska […]
Blood-Brain-Barrier […]
Zone 10 returns 2.51% Ni & 0.77% Cu over 16.35 metres […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com